Search results - 8 results
EBoD-FL. Guidelines for mapping the environmental burden of disease in Flanders, 2023
health outcomes. The risk factors that were prioritised are those related to air quality, environmental noise and extreme temperature. In terms of outcomes, priority was given to all-cause mortality, ...
EBoD-FL. Guidelines for mapping the environmental burden of disease in Flanders
attributable burden as a proportion of the total, figures for the recorded disease burden are required to obtain absolute numbers. In EB oD- FL, the EBD is quantified as disability-adjusted life years (DALY s), ...
Annual Report Belgian Cystic Fibrosis Registry 2018
period at about 3.5% over the years since 2014. Thanks to improved disease management and novel treatments, the life expectancy and the quality of life of patients with CF has improved significantly when ...
Annual Report Belgian Cystic Fibrosis Registry 2017
2014. Thanks to improved disease management and novel treatments, the life expectancy and the quality of life of patients with CF has improved significantly when compared to CF cohorts a decade or two ...
Annual report Belgian Cystic Fibrosis Registry 2016
practises and novel treatments, the life expectancy and the quality of life of patients with CF has improved significantly when compared to CF cohorts a decade or two ago. The proportion of adult CF patients ...
Enquête de santé 2013, rapport 1: état de santé et bien-être
health pain Quality of Life rapport santé sick leave subjective health Health Topics: Health and disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart brengen ...
Final report: MY DNA, EVERYBODY’S BUSINESS? Qualitative analysis of the belgian citizen forum on the use of genomic information
information of the individuals over a life-course period. In short, the genomic revolution is everybody’s business. Therefore, Sciensano and the King Baudouin Foundation (KBF) organized a Belgian citizen forum ...
IPAAC Rapport WP4: Cancer control policy interview survey
design’ is crucial and requires global strategies and resources. In a context of increasing prevalence the lack of data on the whole disease trajectory, including quality of life and survivorship, is ...